'US FDA panel backs Replimune skin cancer drug study data'- Reuters

Benzinga Newsdesk Jul 30, 2026 3 months ago

NewsGeneral

https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-panel-backs-replimune-skin-cancer-drug-study-data-2026-07-30/